GRPR and pachyonychia congenita: The radioactive ligand 125I-Tyr4-bombesin was utilized to examine the expression of GRPR, and the positive expression rate of GRPR in invasive PC (30/30) and in prostatic intraepithelial proliferative lesions (26/26) was found 100%.